International Clinical Trial: Study on the Effects of SGLT2 Inhibitors on Prothrombotic State in Coronary Artery Disease and the Regulation of TRPC3/NCX1 Pathways

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132221) titled 'Study on the Effects of SGLT2 Inhibitors on Prothrombotic State in Coronary Artery Disease and the Regulation of TRPC3/NCX1 Pathways' on Sept. 10.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shijiazhuang People's Hospital

Condition: Coronary Artery Disease

Intervention: Drug Exposure Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-30

Target Sample Size: Drug Exposure Group:180;Non-Exposure Group:180;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=322467

Published by HT Di...